/ mRNA
/ Market Analysis
Why Is Moderna (MRNA) Stock Rising Today? $2.25B Patent Settlement
Moderna stock is rising after the company agreed to pay up to $2.25 billion to settle a patent dispute over technology used in its COVID-19 vaccine.
March 04, 2026
Why Is Moderna Stock Moving Today? Europe Clears Moderna’s Dual Vaccine
Moderna shares swung in early trading after European regulators backed its combination flu-COVID vaccine.
February 27, 2026
Why Is Moderna (MRNA) Stock Down Premarket? FDA Rejects Flu Vaccine Filing
Moderna stock dropped over 9% in premarket trading after the FDA refused to review its mRNA-based flu vaccine, citing inadequate study design.
February 11, 2026
Why Is Moderna (MRNA) Stock Up Today: Merck Partnered Vaccine Cuts Recurrence Risk
Moderna stock rose over 7% after the company and Merck said their personalized melanoma vaccine kept working at five years, cutting recurrence or death risk by 49%.
January 21, 2026
Moderna Stock Drops as FDA Signals New Restrictions on Vaccine Approvals
Moderna shares fell over 4% after the FDA signaled stricter vaccine approval rules, raising concerns about potential delays for new vaccines.
December 01, 2025More from The Tokenist / mRNA
Trump Admin. Reconsiders $590M Funding for Moderna’s Bird Flu Vaccine
February 27, 2025
Moderna Slashes R&D Budget, Stock Plummets Amid Profitability Concerns
September 12, 2024
Stocks to Watch Today: MRNA, META, and AMAT
August 01, 2024
Stocks to Watch Today: TSLA, RIVN, and Moderna
June 26, 2024
Back to 
